2001
DOI: 10.1016/s0008-6215(01)00079-9
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of a carbocyclic sialic acid analogue for the inhibition of influenza virus neuraminidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 16 publications
0
18
0
Order By: Relevance
“…Taxodione and taxodone are two potent antitumor agents3536. Shikimic acid is one component of the T. distichum extract and is classified as a carbocyclic sialic acid analogue3738 that is potentially able to inhibit NA function38. Among the variety of compounds that are present in T. distichum , quercetin has been reported to inhibit replication of hepatitis C virus, herpesvirus 1, rhinovirus, Japanese encephalitis virus, Mayaro virus, dengue virus type-2 and influenza virus (including H1N1 and H5N1)3940414243444546.…”
Section: Discussionmentioning
confidence: 99%
“…Taxodione and taxodone are two potent antitumor agents3536. Shikimic acid is one component of the T. distichum extract and is classified as a carbocyclic sialic acid analogue3738 that is potentially able to inhibit NA function38. Among the variety of compounds that are present in T. distichum , quercetin has been reported to inhibit replication of hepatitis C virus, herpesvirus 1, rhinovirus, Japanese encephalitis virus, Mayaro virus, dengue virus type-2 and influenza virus (including H1N1 and H5N1)3940414243444546.…”
Section: Discussionmentioning
confidence: 99%
“…EBN from Gua Madai contained 6.7 mg/g of Neu5Ac, which is higher than EBN collected from Teluk Intan which contained 3.2 mg/g of Neu5Ac (Haghani et al, 2017). SA residues could interact with the neuraminidase, and prevent this enzyme from cleaving the SA receptor present on the host cell surface hence halting the viral spread and release (Bianco et al, 2001;Haghani et al, 2016;Benton et al, 2017). Treatment with EBN for 24 h after the MDCK cells were inoculated with IAV for 1 h had the highest antiviral activity and percentage of protection against IAV when compared to EBN pre-treatment (MDCK cells treated with EBN for 1 h before IAV inoculation) and cotreatment (MDCK cells treated with EBN and IAV at the same time for 1 h) groups.…”
Section: Antiviral Immunomodulatory and Antimicrobial Actionsmentioning
confidence: 90%
“…Subsequently, the structures of the planar sialic acid transition state during the neuraminidase reaction became available. The analogous compounds of sialic acid’s transition state based on benzoic and shikimic acids, and subsequently the drug Oseltamivir [76,77,78,79], benefit from the increased affinity to neuraminidase compared to the native Neu5Ac structure [80,81]. Unfortunately, the family of compounds related to Zanamivir or Oseltamivir do not act against viruses that do not possess neuraminidase activity but instead engage undistorted sialic acids via a hemagglutinin (e.g., many non-enveloped viruses discussed in chapter 2 of this review).…”
Section: Sialic Acid-based Design Of Anti-viral Compoundsmentioning
confidence: 99%